C H Kuo

Title: C H Kuo - Innovator in Cholesterol-Lowering Compounds

Introduction

C H Kuo is a notable inventor based in South Plainfield, NJ, whose work has significantly contributed to the field of medicinal chemistry. With a focus on developing innovative cholesterol-lowering agents, Kuo has made strides in creating compounds that not only address cholesterol levels but also have potential applications in treating cancer.

Latest Patents

C H Kuo holds one patent titled "Cholesterol-lowering agents." This invention relates to compounds of a specific structural formula that are identified as squalene synthase inhibitors. These compounds are beneficial as cholesterol-lowering agents and antifungal agents. Additionally, they inhibit farnesyl protein transferase and the farnesylation of the oncogene protein Ras, suggesting their utility in cancer treatment.

Career Highlights

Kuo's career is marked by his association with Merck & Company, Inc., a leading global pharmaceutical company. His innovative approach to medicinal chemistry and drug development has been essential in tackling health issues related to cholesterol and cancer.

Collaborations

Throughout his career, C H Kuo has collaborated with prominent professionals in his field. Notable coworkers include Gregory D Berger and James D Bergstrom, with whom he has worked to advance research and development initiatives in pharmaceuticals.

Conclusion

C H Kuo exemplifies the impact of innovation and research in the pharmaceutical industry. His contributions, particularly through his patent on cholesterol-lowering agents, highlight the importance of continuous advancements in medicine and the collaboration between inventors and industry professionals.